| answer text |
<p>The UK Medical Research Council (MRC) leads the UK Government relationship with
the European and Developing Countries Clinical Trials Partnership (EDCTP). Over the
period 2013-2018, DFID will provide £10 million to EDCTP through the MRC. In addition
DFID support for product development research is counted as a Member State contribution
to EDCTP.</p><p> </p><p> </p><p> </p><p>DFID contributes to a number of innovative
product development partnerships (PDPs) for the development of drugs, vaccines, diagnostics
and other technologies for diseases of poverty. Funding of £138 million for 2013-2018
was announced in August 2013 and includes support for the TB Alliance, the International
AIDS vaccine Initiative and eight other PDPs (details of the awards were published
in August 2013 and can be found at:</p><p> </p><p><a href="https://www.gov.uk/government/news/dfid-invests-to-save-millions-from-deadly-diseases"
target="_blank">https://www.gov.uk/government/news/dfid-invests-to-save-millions-from-deadly-diseases</a>).
In addition over the period 2012-2017, DFID will provide £6.5 million for the Saving
Lives at Birth programme in partnership with the Bill and Melinda Gates Foundation,
US Government, Norwegian Government and Grand Challenges Canada. This programme is
supporting new technologies to prevent mothers and babies dying at birth.</p><p> </p>
|
|
